Company news

Optimizerx Corporation (NASDAQ:OPRX) news

Optimizerx Corporation news releases on 6ix. Latest, Sep 22, 2026: OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

Optimizerx Corporation (NASDAQ:OPRX) news

Press releases & updates

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth

OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET

OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer

OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms

DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET

OptimizeRx Appoints Mary Varghese Presti to Board of Directors

UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET

OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing

OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network

OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET

OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Paynela Appoints Healthcare Technology Veteran William Febbo to Board of Directors

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

OptimizeRx to Participate in Upcoming Investor Conferences

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

OptimizeRx Reports Third Quarter 2024 Financial Results

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

OptimizeRx Reports Second Quarter 2024 Financial Results

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients

New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations